RECURSION PHARMACEUTICALS, INC. Deferred Tax Assets, Goodwill and Intangible Assets
RECURSION PHARMACEUTICALS, INC. (RXRX) had Deferred Tax Assets, Goodwill and Intangible Assets of $0 as of 2023-12-31, per its 10-K filed 2024-02-29.
Discontinued › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets · last filed 2024-02-29
- 2023-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $0.00.
- 2022-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $969.00K.
- 2021-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $1.00M.
- 2020-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $1.11M.
| Period end | Deferred Tax Assets, Goodwill and Intangible Assets |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-29 |
| 2022-12-31 | $969.00K 10-K · filed 2024-02-29 |
| 2021-12-31 | $1.00M 10-K · filed 2023-02-27 |
| 2020-12-31 | $1.11M 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |